INVENIA Co., Ltd.

As of March 31, 2026, INVENIA Co., Ltd. carries a market capitalization of 13.71B, placing it among publicly traded companies globally. Its enterprise value stands at 25.93B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, INVENIA Co., Ltd. has 13.44M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.24, and the price-to-book ratio stands at 0.56.

These figures are as of March 31, 2026. The EV/Sales ratio of 0.86 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 25.93B versus a market cap of 13.71B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, INVENIA Co., Ltd. maintains a current ratio of 0.94, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 101.26, indicating elevated leverage, while an interest coverage ratio of -3.42 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, INVENIA Co., Ltd. posted a negative return on equity (ROE) of -30.64, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -10.68, reflecting losses generated across the asset base. The company generates approximately 391.94M in revenue per employee across its workforce of 76.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.63 indicates how many times INVENIA Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, INVENIA Co., Ltd. recorded an income tax benefit of -290.22M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -7.34B and -7.05B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, INVENIA Co., Ltd.'s stock has declined approximately 77.15% over the past 52 weeks. The 50-day moving average sits at 1,266.32, while the 200-day moving average is 1,473.06.

Over the twelve months ended March 31, 2026, INVENIA Co., Ltd. generated 29.98B in revenue and converted that into -7.05B in net income, yielding earnings per share of -996.08. EBITDA reached -5.41B, while operating income came in at -5.80B.

As of March 31, 2026, INVENIA Co., Ltd. holds 12.60B in cash and equivalents against 24.82B in total debt, resulting in a net debt position of 12.02B. Total book value stands at 24.51B, with working capital of -1.96B providing operational flexibility.

INVENIA Co., Ltd. produced 3.79B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -58.71M in capital expenditures, free cash flow totaled 3.73B - equivalent to 527.37 per share.

Over the twelve months ended March 31, 2026, INVENIA Co., Ltd. posted a gross margin of 6.01, reflecting its pricing power and cost economics. The operating margin of -19.34 and net profit margin of -23.51 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 51.70, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -51.57, meaning INVENIA Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

INVENIA Co., Ltd.'s most recent stock split took place on December 26, 2025 with a 101:131 split ratio.

As of March 31, 2026, INVENIA Co., Ltd. has an Altman Z-Score of 0.19, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.